GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invion Ltd (ASX:IVX) » Definitions » Total Equity

Invion (ASX:IVX) Total Equity : A$13.13 Mil (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Invion Total Equity?

Invion's total equity for the quarter that ended in Dec. 2024 was A$13.13 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Invion Total Equity Historical Data

The historical data trend for Invion's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invion Total Equity Chart

Invion Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.43 4.79 19.58 18.40 14.44

Invion Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.03 18.40 17.86 14.44 13.13

Invion Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Invion's Total Equity for the fiscal year that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=15.451-1.014
=14.44

Invion's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=13.851-0.722
=13.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invion Total Equity Related Terms

Thank you for viewing the detailed overview of Invion's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Invion Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invion Ltd (ASX:IVX) » Definitions » Total Equity
Comparable Companies
ASX:EXL ASX:EOF ASX:RGT ASX:AGH ASX:PER ASX:BP8 ASX:CAN ASX:ECS ASX:NXS ASX:LGP ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
IVIXF:USA 7C8:Germany
Address
692 High Street, East Kew, VIC, AUS, 3102
Website
https://www.inviongroup.com
Invion Ltd is an Australian clinical-stage pharmaceutical drug development company. It is engaged in the development of PhotoDynamic Therapy (PDT) for cancer treatments called Photosoft, for the treatment of a range of cancers and infectious diseases. The company produces topical and intravenous products suitable for use in skin cancer and solid tumors, such as ovarian, prostate, and lung cancer. Invion has developed a portfolio of patent protected compounds. Its drug candidate is INV043, a novel photosensitiser which has the potential to work as a therapy and a diagnostic tool.

Invion Headlines

No Headlines